title: [Multidrug resistance tuberculosis - current problems].
abstract: The rising occurrence of multidrug-resistant tuberculosis (MDR-TB), defined as resistance to at least isoniazid and rifampicin, is a serious worldwide problem. The treatment of MDR-TB with alternative chemotherapy is difficult due to side-effects and treatment duration. It is also very expensive and sometimes unsuccessful. DOTS and DOTS-Plus strategy are necessary to achieve a good tuberculosis control.
authors: Klinika Pulmonologii, II Katedra Chorób Wewnetrznych Collegium Medicum Uniwersytetu Jagiellonskiego w Krakowie Kierownik. krucza@gmail.com
authors: Katarzyna
authors: K
authors: Kruczak
authors: Ewa
authors: E
authors: Nizankowska-Mogilnicka
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003140:Communicable Disease Control / Q000458:organization & administration; D023801:Directly Observed Therapy / Q000379:methods*; D014943:Global Health; D006801:Humans; D011322:Primary Prevention / Q000458:organization & administration; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D014944:World Health Organization
chemical_list: D000995:Antitubercular Agents